- $1.25bn
- $1.14bn
- $500.89m
- 88
- 47
- 98
- 92
Annual balance sheet for Proto Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 162 | 77.5 | 80.1 | 103 | 103 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 58.4 | 81.4 | 80.3 | 75.1 | 69.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 242 | 183 | 187 | 201 | 195 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 295 | 288 | 279 | 259 | 231 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 744 | 929 | 802 | 772 | 744 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 50.3 | 54.9 | 71.6 | 49.7 | 53.3 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 99.8 | 100 | 105 | 77.1 | 73.4 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 644 | 828 | 698 | 695 | 670 |
| Total Liabilities & Shareholders' Equity | 744 | 929 | 802 | 772 | 744 |
| Total Common Shares Outstanding |